BioVie Inc.
BIVI
$7.14
-$0.43-5.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.79M | -7.11M | -4.15M | -4.94M | -8.07M |
| Total Depreciation and Amortization | 57.30K | 57.30K | 57.30K | 57.30K | 57.30K |
| Total Amortization of Deferred Charges | 0.00 | 2.40K | 9.50K | 16.50K | 798.90K |
| Total Other Non-Cash Items | 693.50K | 701.00K | 576.80K | 1.71M | 425.30K |
| Change in Net Operating Assets | 784.10K | -2.23M | -71.10K | -851.00K | 934.70K |
| Cash from Operations | -1.25M | -8.58M | -3.58M | -4.01M | -5.85M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 2.90M | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -3.35M | -2.50M | -2.50M | -2.50M |
| Issuance of Common Stock | -- | 16.32M | 2.26M | 0.00 | 18.48M |
| Repurchase of Common Stock | -2.90M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 12.97M | -240.90K | -2.50M | 15.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.25M | 4.38M | -3.82M | -6.51M | 10.12M |